Press release
Intravenous Immunoglobulin (IVIg) Market Projected to Reach USD 18.99 Billion, with a Robust 3.96% CAGR Till 2035
Intravenous Immunoglobulin (IVIg) Market
Intravenous Immunoglobulin (IVIg) therapy has emerged as one of the most significant medical advancements in the treatment of immune-related and neurological disorders. Derived from pooled human plasma, IVIg contains concentrated antibodies that help regulate immune system activity, making it a vital therapeutic option for patients suffering from autoimmune diseases, immunodeficiency conditions, and inflammatory disorders. As healthcare systems continue to prioritize advanced biologic therapies, IVIg is gaining increasing recognition for its clinical effectiveness and broad therapeutic applications.
Intravenous Immunoglobulin Market Size was estimated at 12.39 USD Billion in 2024. The Intravenous Immunoglobulin industry is projected to grow from 12.88 USD Billion in 2025 to 18.99 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 3.96% during the forecast period 2025 - 2035.
Request Your Sample Copy of This Strategic Report: https://www.marketresearchfuture.com/sample_request/3137
IVIg therapy works by providing patients with essential immunoglobulin G (IgG) antibodies that strengthen immune responses or modulate abnormal immune activity. For individuals with primary immunodeficiency diseases, whose bodies cannot produce sufficient antibodies, IVIg acts as a replacement therapy that helps prevent recurrent infections. At the same time, it plays a crucial role in treating autoimmune disorders by suppressing harmful immune reactions that mistakenly attack healthy tissues.
The growing prevalence of chronic immune-mediated diseases has significantly contributed to the rising adoption of IVIg therapy worldwide. Conditions such as Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and immune thrombocytopenia are increasingly managed using IVIg due to its proven safety and efficacy. Physicians often prefer IVIg because it offers rapid therapeutic response and can be administered in both hospital and specialized infusion center settings.
Technological advancements in plasma fractionation and purification processes have further improved the safety profile of IVIg products. Modern manufacturing techniques ensure rigorous screening and viral inactivation procedures, minimizing risks associated with plasma-derived therapies. These improvements have enhanced patient confidence and supported wider regulatory approvals across global healthcare markets.
You Can Purchase Complete Report: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=3137
Another factor driving the expansion of IVIg therapy is the growing awareness among healthcare professionals regarding early diagnosis of immunological disorders. Early intervention with IVIg can significantly improve patient outcomes, reduce hospitalization rates, and enhance quality of life. In pediatric care especially, IVIg has become an essential treatment option for managing congenital immune deficiencies and certain inflammatory conditions.
Healthcare infrastructure development and increasing investment in biologics research are also accelerating innovation in IVIg formulations. Manufacturers are focusing on improving product stability, reducing infusion times, and enhancing patient convenience. The introduction of more concentrated formulations and optimized dosing protocols allows healthcare providers to tailor treatments according to individual patient needs, supporting personalized medicine approaches.
Despite its clinical advantages, IVIg therapy faces certain challenges, primarily related to plasma supply limitations and treatment costs. Since IVIg depends on human plasma donations, maintaining a consistent global supply remains critical. Governments, healthcare organizations, and plasma collection networks are actively promoting donation programs to address this challenge and ensure uninterrupted treatment availability.
Related Report:
Chlorhexidine Gluconate Wipes Market : https://www.marketresearchfuture.com/reports/chlorhexidine-gluconate-wipes-market-7564
UK Chlorhexidine Gluconate Wipes Market : https://www.marketresearchfuture.com/reports/uk-chlorhexidine-gluconate-wipes-market-49600
Clinical Trial Management System Market : https://www.marketresearchfuture.com/reports/clinical-trial-management-system-market-2054
US Clinical Trial Management System Market : https://www.marketresearchfuture.com/reports/us-clinical-trial-management-system-market-17657
Concussions Market : https://www.marketresearchfuture.com/reports/concussions-market-5724
Cosmetic Surgery Market : https://www.marketresearchfuture.com/reports/cosmetic-surgery-market-3157
Cystic Fibrosis Market : https://www.marketresearchfuture.com/reports/cystic-fibrosis-market-1825
China Dental Biomaterials Market : https://www.marketresearchfuture.com/reports/china-dental-biomaterials-market-50519
Dental Biomaterials Market : https://www.marketresearchfuture.com/reports/dental-biomaterials-market-7526
Dental Bone Graft Market : https://www.marketresearchfuture.com/reports/dental-bone-graft-market-867
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin (IVIg) Market Projected to Reach USD 18.99 Billion, with a Robust 3.96% CAGR Till 2035 here
News-ID: 4395698 • Views: …
More Releases from market research future
Intraocular Lens Market Expected to Hit USD 9.28 Billion by 2035 with a Remarkab …
Intraocular Lens Market Poised for Transformative Growth with Advanced Technologies
The global Intraocular Lens (IOL) market is witnessing remarkable advancements, driven by innovations in ophthalmic technologies and increasing demand for vision correction procedures. An intraocular lens, a medical device implanted in the eye to replace the eye's natural lens, plays a pivotal role in restoring vision for patients suffering from cataracts, presbyopia, and other refractive errors. As the prevalence of eye…
Biopharmaceuticals Market to Reach USD 550.14 Billion by 2035, Expanding at 4.21 …
The global biopharmaceuticals market is experiencing steady expansion as technological advancements, rising demand for targeted therapies, and increasing investments in research and development continue to transform the healthcare landscape. Biopharmaceuticals, which include biologics, biosimilars, vaccines, and advanced therapeutic products, are becoming central to modern treatment approaches for complex and chronic diseases. According to recent insights from Market Research Future, the industry is expected to maintain consistent growth over the next…
Bioidentical Hormones Market to Reach USD 4.362 Billion by 2035, Driven by Risin …
The global bioidentical hormones market is experiencing consistent expansion as healthcare systems increasingly adopt personalized treatment approaches for hormone-related disorders. Growing awareness about hormone replacement therapies, increasing aging populations, and rising prevalence of endocrine disorders are key factors supporting market growth. According to recent insights from Market Research Future, the market is expected to maintain a steady growth trajectory over the next decade.
As per Market Research Future analysis, the Bioidentical…
Bilirubin Blood Test Market to Reach USD 2.528 Billion by 2035, Driven by Rising …
The global bilirubin blood test market is witnessing consistent expansion driven by increasing awareness of liver health, growing prevalence of liver disorders, and rising demand for early diagnostic solutions. Bilirubin testing plays a critical role in assessing liver function, diagnosing jaundice, and monitoring various medical conditions. According to recent insights from Market Research Future, the market is expected to demonstrate strong and sustained growth over the next decade.
As per Market…
More Releases for IVIg
IVIg Powder Market 2022-2028 Global Key Manufacturers' Analysis Review
The "Global IVIg Powder Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the IVIg Powder market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading IVIg Powder market players and offers key trends…
Intravenous Immunoglobulin (IVIG) Market Size, Share | Industry Report 2026
The global Intravenous Immunoglobulin Market was valued at $13.7Billion in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $16.7Billion.
Intravenous Immunoglobulin (IVIG) is a solution of highly purified immunoglobulin G, derived from large human plasma that contains antibodies against a broad spectrum of bacterial and viral agents. Intravenous immunoglobulin of properties isa composition that addition of albumin,…
Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Dise …
This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails.
Secondary research…
Intravenous Immunoglobulin (IVIG) Market: Rising Production of IVIG Products are …
The global market for intravenous immunoglobulin (IVIG) products and therapies is heading in a positive direction due to several innovative techniques and advantages it offers to clinicians worldwide. The market is expected to expand at a healthy pace in the near future. Factors that will support market’s growth include technological improvements in the methods used for production and purification of IVIG products and an improving health care infrastructure across the…
Global Intravenous Immunoglobulin (IVIg) Market
The Intravenous Immunoglobulin Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from…
Global Intravenous Immunoglobulin (IVIG) Market: Rising Patient Pool of Neurolog …
The global intravenous immunoglobulin (IVIG) market is largely consolidated, with top four players: Grifols S.A., CSL Behring LLC, Baxalta Incorporated, and Octapharma AG, accounting for over 70% of the overall market in 2015. Grifols S.A. accounted for the dominant share of 23.0%, chiefly on account of the company’s strong geographic penetration.
Oligopoly in the market has led to intense competition among top players and has compelled companies to take course of…
